We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Drinking Coffee Daily Lowers Risk for Chronic Hepatitis C Progression

By HospiMedica International staff writers
Posted on 17 Nov 2009
Drinking three or more cups of coffee per day is linked to a lower risk for progression of chronic hepatitis C, according to the results of a new study.

Researchers at the U.S. More...
National Cancer Institute (NCI; Rockville, MD, USA) examined the relationship of coffee consumption with liver disease progression in 766 patients with advanced hepatitis C-related liver disease participating in the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis (HALT-C) trial. Baseline coffee and tea intake were assessed in those patients who had bridging fibrosis or cirrhosis on liver biopsy, and who also failed to achieve a sustained virological response to peginterferon plus ribavirin treatment. The participants were followed for 3.8 years to evaluate clinical outcomes.

The researchers found that at baseline, higher coffee consumption was associated with less severe steatosis on biopsy, lower serum aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ratio, alpha-fetoprotein, insulin, and homeostatic model assessment (HOMA2) score, and higher albumin. Outcome rates in person-years (PY) of 230 of these patients declined with increasing coffee intake: 11.1/100 PY for none, 12.1 for less than 1 cup per day, 8.2 for 1 to fewer than 3 cups per day, and 6.3 for 3 or more cups per day. Relative risk ratios were 1.11 for less than 1 cup per day; 0.70 for 1 to fewer than 3 cups per day; and 0.47 for 3 or more cups per day, when compared to not drinking; the risk estimates did not vary by treatment assignment or cirrhosis status at baseline, and tea (either green or black) intake was not associated with outcomes. The study was published in the November 2009 issue of Hepatology.

"Given the large number of people affected by hepatitis C it is important to identify modifiable risk factors associated with the progression of liver disease,” said lead author Neal Freedman, Ph.D., M.P.H., of the division of cancer epidemiology and genetics. "Although we cannot rule out a possible role for other factors that go along with drinking coffee, results from our study suggest that patients with high coffee intake had a lower risk of disease progression.”

Recent research into coffee's health benefits has revealed some surprising associations with coffee consumption, including decreased risks of alcoholic cirrhosis, type 2 diabetes, gallstone development, liver damage in those with liver disease, and liver cancer.

Related Links:
U.S. National Cancer Institute




Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.